Global Diagnostic Electrocardiograph market size is expected to reach $11.39 billion by 2029 at 6.9%, segmented as by resting electrocardiogram (ecg), 1-channel ecg, 3-channel ecg, 6-channel ecg, 12-channel ecg
Read MoreGlobal Diagnostic Contract Manufacturing market size is expected to reach $61.46 billion by 2029 at 14.4%, segmented as by device development and manufacturing services, product design and prototyping, regulatory affairs and compliance
Read MoreGlobal Diabetic Wounds market size is expected to reach $3.11 billion by 2029 at 7.3%, segmented as by wound care dressings, hydrocolloid dressings, foam dressings, alginate dressings, film dressings, hydrogels, antimicrobial dressings
Read MoreGlobal Dermatophytosis Treatment market size is expected to reach $14.2 billion by 2029 at 6.4%, segmented as by prescribed, oral antifungal medications, topical antifungal medications, combination therapy
Read MoreGlobal Dental Tourism market size is expected to reach $11.61 billion by 2029 at 12.3%, segmented as by dental implants, single tooth implants, multiple tooth implants, full-mouth implants
Read MoreGlobal Dental Impression Material market size is expected to reach $1.3 billion by 2029 at 10.6%, segmented as by alginate, fast-setting alginate, regular-setting alginate
Read MoreGlobal Dental Implants And Prosthetics Contract Manufacturing market size is expected to reach $6.65 billion by 2029 at 8.5%, segmented as by dental implants, endosteal implants, subperiosteal implants, zygomatic implants
Read MoreGlobal Dental Fluoride Treatment market size is expected to reach $20.3 billion by 2029 at 5.8%, segmented as by topical, fluoride gels, fluoride varnishes, fluoride foams, fluoride mouth rinses, toothpastes with fluoride
Read MoreGlobal Dendritic Cell Cancer Vaccine market size is expected to reach $4 billion by 2029 at 10.1%, segmented as by creavax, creavax in clinical trials, creavax commercialization
Read MoreGlobal C-X-C Chemokine Receptor 4 (CXCR4) Antagonists market size is expected to reach $2.54 billion by 2029 at 9.3%, segmented as by bl-8040, oncology applications (leukemia, lymphoma), stem cell mobilization
Read More
